Figure 1.
Cumulative probability of not developing renal disease in GLADEL (Grupo Latino Americano De Estudio de Lupus) as a function of antimalarial intake by Kaplan-Meier survival analyses.
Cumulative probability of not developing renal disease in GLADEL (Grupo Latino Americano De Estudio de Lupus) as a function of antimalarial intake by Kaplan-Meier survival analyses.